Prevention of febrile neutropenia: use of prophylactic antibiotics

Febrile neutropenia (FN) causes significant morbidity and mortality in patients receiving cytotoxic chemotherapy and can lead to reduced chemotherapy dose intensity and increased overall treatment costs. Antibiotic prophylaxis reduces the incidence of FN. Recent research and meta-analyses confirm th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cullen, M, Baijal, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752225/
https://www.ncbi.nlm.nih.gov/pubmed/19756000
http://dx.doi.org/10.1038/sj.bjc.6605270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752225/
https://www.ncbi.nlm.nih.gov/pubmed/19756000
http://dx.doi.org/10.1038/sj.bjc.6605270

Ejemplares similares